Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

58 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Everolimus is an active agent in medullary thyroid cancer: a clinical and in vitro study.
Faggiano A, Ramundo V, Dicitore A, Castiglioni S, Borghi MO, Severino R, Ferolla P, Crinò L, Abbruzzese A, Sperlongano P, Caraglia M, Ferone D, Hofland L, Colao A, Vitale G. Faggiano A, et al. Among authors: ferolla p. J Cell Mol Med. 2012 Jul;16(7):1563-72. doi: 10.1111/j.1582-4934.2011.01438.x. J Cell Mol Med. 2012. PMID: 21883896 Free PMC article.
Epidemiology of non-gastroenteropancreatic (neuro)endocrine tumours.
Ferolla P, Faggiano A, Avenia N, Milone F, Masone S, Giampaglia F, Puma F, Daddi G, Angeletti G, Lombardi G, Santeusanio F, Colao A. Ferolla P, et al. Clin Endocrinol (Oxf). 2007 Jan;66(1):1-6. doi: 10.1111/j.1365-2265.2006.02739.x. Clin Endocrinol (Oxf). 2007. PMID: 17201794 Review.
Secretive and proliferative tumor profile helps to select the best imaging technique to identify postoperative persistent or relapsing medullary thyroid cancer.
Faggiano A, Grimaldi F, Pezzullo L, Chiofalo MG, Caracò C, Mozzillo N, Angeletti G, Santeusanio F, Lombardi G, Colao A, Avenia N, Ferolla P. Faggiano A, et al. Among authors: ferolla p. Endocr Relat Cancer. 2009 Mar;16(1):225-31. doi: 10.1677/ERC-08-0152. Epub 2008 Nov 12. Endocr Relat Cancer. 2009. PMID: 19004986
CDKN1B V109G polymorphism a new prognostic factor in sporadic medullary thyroid carcinoma.
Pasquali D, Circelli L, Faggiano A, Pancione M, Renzullo A, Elisei R, Romei C, Accardo G, Coppola VR, De Palma M, Ferolla P, Grimaldi F, Colao A, Colantuoni V. Pasquali D, et al. Among authors: ferolla p. Eur J Endocrinol. 2011 Mar;164(3):397-404. doi: 10.1530/EJE-10-0929. Epub 2010 Dec 21. Eur J Endocrinol. 2011. PMID: 21177330
Shortened interval of long-acting octreotide administration is effective in patients with well-differentiated neuroendocrine carcinomas in progression on standard doses.
Ferolla P, Faggiano A, Grimaldi F, Ferone D, Scarpelli G, Ramundo V, Severino R, Bellucci MC, Camera LM, Lombardi G, Angeletti G, Colao A. Ferolla P, et al. J Endocrinol Invest. 2012 Mar;35(3):326-31. doi: 10.3275/7869. Epub 2011 Jul 13. J Endocrinol Invest. 2012. PMID: 21757992 Clinical Trial.
Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian epidemiological study: the NET management study.
Faggiano A, Ferolla P, Grimaldi F, Campana D, Manzoni M, Davì MV, Bianchi A, Valcavi R, Papini E, Giuffrida D, Ferone D, Fanciulli G, Arnaldi G, Franchi GM, Francia G, Fasola G, Crinò L, Pontecorvi A, Tomassetti P, Colao A. Faggiano A, et al. Among authors: ferolla p. J Endocrinol Invest. 2012 Oct;35(9):817-23. doi: 10.3275/8102. Epub 2011 Nov 9. J Endocrinol Invest. 2012. PMID: 22080849
Clinical management of patients with gastric neuroendocrine neoplasms associated with chronic atrophic gastritis: a retrospective, multicentre study.
Campana D, Ravizza D, Ferolla P, Faggiano A, Grimaldi F, Albertelli M, Berretti D, Castellani D, Cacciari G, Fazio N, Colao A, Ferone D, Tomassetti P. Campana D, et al. Among authors: ferolla p. Endocrine. 2016 Jan;51(1):131-9. doi: 10.1007/s12020-015-0584-z. Epub 2015 Mar 27. Endocrine. 2016. PMID: 25814125
58 results